Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT06795412 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: PYX-201
DRUG: pembrolizumab

Sponsor

Pyxis Oncology, Inc

Collaborators

[object Object]